Zevra Therapeutics (ZVRA) Cash from Investing Activities Growth (1y) (2015 - 2026)
Zevra Therapeutics (ZVRA) Cash from Investing Activities Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Zevra Therapeutics |
787.90 Mn |
587.28 Mn |
34.30 Mn |
655.25% |
| Date | Value |
|---|
| Mar 31, 2026 |
655.25% |
| Dec 31, 2025 |
104.15% |
| Sep 30, 2025 |
85.41% |
| Jun 30, 2025 |
9,351.16% |
| Mar 31, 2025 |
-28.74% |
| Dec 31, 2024 |
-151.69% |
| Sep 30, 2024 |
29.47% |
| Jun 30, 2024 |
-100.38% |
| Mar 31, 2024 |
184.27% |
| Dec 31, 2023 |
16,901.59% |
| Sep 30, 2023 |
-16,444.12% |
| Jun 30, 2023 |
202.89% |
| Mar 31, 2023 |
-356.21% |
| Dec 31, 2022 |
99.59% |
| Sep 30, 2022 |
6,900.00% |
| Jun 30, 2022 |
-40,739.51% |
| Dec 31, 2021 |
-59,280.77% |
| Jun 30, 2021 |
-2,125.00% |
| Dec 31, 2020 |
-420.00% |
| Mar 31, 2020 |
-100.34% |
